據報中國信達(01359.HK)所持4筆國通信託計劃再次流拍
據內媒《觀點新媒體》報道,中國信達(01359.HK)所持的4筆國通信託計劃受益權及信託費用債權再次流拍,是次起拍價20.41億元人民幣(下同),亦是第四次出現拍賣流拍。
截至基準日,標的信託計劃項下已發生的預計信託費用爲1.43億元;自基準日至交割日期間,如信達墊付新增信託報酬、底層房產託管服務費等新增信託費用,該新增墊付信託費用均屬於信託費用債權。
該計劃在2023年7月15日持有北京市朝陽區大屯里316號樓及317號樓部分房產、對北京政泉控股有限公司餘額爲476.7萬元的債權,以及對盤古氏國際大酒店有限責任公司餘額約爲3.38億元的債權。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.